{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:39:09Z","timestamp":1777437549702,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,20]]},"DOI":"10.7759\/cureus.40703","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:42:20Z","timestamp":1687308140000},"source":"Crossref","is-referenced-by-count":1,"title":["Neuroendocrine Tumor Metastases to the Breast: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Jose A","family":"Urrego D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Ernesto","family":"Romero-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Strosberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Jim\u00e9nez-V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet J","year":"2015","unstructured":"Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015, 121:589-97. 10.1002\/cncr.29099","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Shah MH","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB, et al.. Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021, 19:839-68. 10.6004\/jnccn.2021.0032","journal-title":"J Natl Compr Canc Netw"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky B","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017, 19:991-1002. 10.1016\/j.neo.2017.09.002","journal-title":"Neoplasia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2042018818804698","article-title":"Current best practice in the management of neuroendocrine tumors","volume":"10","author":"Tsoli M","year":"2019","unstructured":"Tsoli M, Chatzellis E, Koumarianou A, Kolomodi D, Kaltsas G. Current best practice in the management of neuroendocrine tumors. Ther Adv Endocrinol Metab. 2019, 10:2042018818804698. 10.1177\/2042018818804698","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours","volume":"80","author":"Taal BG","year":"2004","unstructured":"Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004, 80:3-7. 10.1159\/000080731","journal-title":"Neuroendocrinology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1179551419884058","article-title":"Management of gastrointestinal neuroendocrine tumors","volume":"12","author":"Wang R","year":"2019","unstructured":"Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB. Management of gastrointestinal neuroendocrine tumors. Clin Med Insights Endocrinol Diabetes. 2019, 12:1179551419884058. 10.1177\/1179551419884058","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al.. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020, 76:182-8. 10.1111\/his.13975","journal-title":"Histopathology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24698","article-title":"European disparities in malignant digestive endocrine tumours survival","volume":"126","author":"Lepage C","year":"2010","unstructured":"Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2010, 126:2928-34. 10.1002\/ijc.24698","journal-title":"Int J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao JC","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al.. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008, 26:3063-72. 10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008215730767","article-title":"Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center","volume":"8","author":"Janson ET","year":"1997","unstructured":"Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol. 1997, 8:685-90. 10.1023\/a:1008215730767","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari A","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al.. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017, 3:1335-42. 10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000441897","article-title":"Changes in the epidemiology of neuroendocrine tumours","volume":"104","author":"Huguet I","year":"2017","unstructured":"Huguet I, Grossman AB, O'Toole D. Changes in the epidemiology of neuroendocrine tumours. Neuroendocrinology. 2017, 104:105-11. 10.1159\/000441897","journal-title":"Neuroendocrinology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27994-2_20","article-title":"Rare metastases detected by (68)Ga-somatostatin receptor PET\/CT in patients with neuroendocrine tumors","volume":"194","author":"Carreras C","year":"2013","unstructured":"Carreras C, Kulkarni HR, Baum RP. Rare metastases detected by (68)Ga-somatostatin receptor PET\/CT in patients with neuroendocrine tumors. Recent Results Cancer Res. 2013, 194:379-84. 10.1007\/978-3-642-27994-2_20","journal-title":"Recent Results Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014989","article-title":"A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: a diagnostic challenge and management dilemma","volume":"98","author":"Papalampros A","year":"2019","unstructured":"Papalampros A, Mpaili E, Moris D, et al.. A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: a diagnostic challenge and management dilemma. Medicine (Baltimore). 2019, 98:e14989. 10.1097\/MD.0000000000014989","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31820b4e19","article-title":"Atypical lung carcinoid metastasis to breast: a case report","volume":"40","author":"Choi JJ","year":"2011","unstructured":"Choi JJ, Buch KE, Warner RR, Divino CM. Atypical lung carcinoid metastasis to breast: a case report. Pancreas. 2011, 40:487-8. 10.1097\/MPA.0b013e31820b4e19","journal-title":"Pancreas"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2011.0018","article-title":"Imaging features of carcinoid tumors metastatic to the breast","volume":"11","author":"Glazebrook KN","year":"2011","unstructured":"Glazebrook KN, Jones KN, Dilaveri CA, Perry K, Reynolds C. Imaging features of carcinoid tumors metastatic to the breast. Cancer Imaging. 2011, 11:109-15. 10.1102\/1470-7330.2011.0018","journal-title":"Cancer Imaging"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.69","article-title":"Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation","volume":"29","author":"Mohanty SK","year":"2016","unstructured":"Mohanty SK, Kim SA, DeLair DF, et al.. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mod Pathol. 2016, 29:788-98. 10.1038\/modpathol.2016.69","journal-title":"Mod Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2007.00557.x","article-title":"Neuroendocrine carcinoma metastatic to the breast","volume":"14","author":"Hwang H","year":"2008","unstructured":"Hwang H, Hou KT, Schiller CL, Wayne JD, Mendelson EB, Susnik B. Neuroendocrine carcinoma metastatic to the breast. Breast J. 2008, 14:201-2. 10.1111\/j.1524-4741.2007.00557.x","journal-title":"Breast J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-013-2037-2","article-title":"Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?","volume":"37","author":"Crona J","year":"2013","unstructured":"Crona J, Granberg D, Norl\u00e9n O, W\u00e4rnberg F, St\u00e5lberg P, Hellman P, Bj\u00f6rklund P. Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?. World J Surg. 2013, 37:1701-6. 10.1007\/s00268-013-2037-2","journal-title":"World J Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20631","article-title":"A metastatic renal carcinoid tumor presenting as breast mass: a diagnostic dilemma","volume":"35","author":"Hasteh F","year":"2007","unstructured":"Hasteh F, Pu R, Michael CW. A metastatic renal carcinoid tumor presenting as breast mass: a diagnostic dilemma. Diagn Cytopathol. 2007, 35:306-10. 10.1002\/dc.20631","journal-title":"Diagn Cytopathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5858\/2004-128-292-PSBCTW","article-title":"Primary small bowel carcinoid tumor with bilateral breast metastases: report of 2 cases with different clinical presentations","volume":"128","author":"Mosunjac MB","year":"2004","unstructured":"Mosunjac MB, Kochhar R, Mosunjac MI, Lau SK. Primary small bowel carcinoid tumor with bilateral breast metastases: report of 2 cases with different clinical presentations. Arch Pathol Lab Med. 2004, 128:292-7. 10.5858\/2004-128-292-PSBCTW","journal-title":"Arch Pathol Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2005.10.021","article-title":"Carcinoid tumors in the breast","volume":"191","author":"Upalakalin JN","year":"2006","unstructured":"Upalakalin JN, Collins LC, Tawa N, Parangi S. Carcinoid tumors in the breast. Am J Surg. 2006, 191:799-805. 10.1016\/j.amjsurg.2005.10.021","journal-title":"Am J Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-4-15","article-title":"Breast metastasis of ilial carcinoid tumor: case report and literature review","volume":"4","author":"Gupta C","year":"2006","unstructured":"Gupta C, Malani AK, Rangineni S. Breast metastasis of ilial carcinoid tumor: case report and literature review. World J Surg Oncol. 2006, 4:15. 10.1186\/1477-7819-4-15","journal-title":"World J Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.03940.x","article-title":"Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma","volume":"59","author":"Perry KD","year":"2011","unstructured":"Perry KD, Reynolds C, Rosen DG, et al.. Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma. Histopathology. 2011, 59:619-30. 10.1111\/j.1365-2559.2011.03940.x","journal-title":"Histopathology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2016.10.011","article-title":"Metastatic carcinoid tumor to the breast: report of two cases and review of the literature","volume":"42","author":"Lee S","year":"2017","unstructured":"Lee S, Levine P, Heller SL, Hernandez O, Mercado CL, Chhor CM. Metastatic carcinoid tumor to the breast: report of two cases and review of the literature. Clin Imaging. 2017, 42:88-92. 10.1016\/j.clinimag.2016.10.011","journal-title":"Clin Imaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2009.n.032","article-title":"Radiologic characteristics and management of screen-detected metastatic carcinoid tumor of the breast: a case report","volume":"9","author":"Adams RF","year":"2009","unstructured":"Adams RF, Parulekar V, Hughes C, Kadour MJ, Talbot D. Radiologic characteristics and management of screen-detected metastatic carcinoid tumor of the breast: a case report. Clin Breast Cancer. 2009, 9:189-92. 10.3816\/CBC.2009.n.032","journal-title":"Clin Breast Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9371-x","article-title":"Breast metastasis as the first clinical manifestation of ileal neuroendocrine tumor. A challenging diagnosis with relevant clinical implications","volume":"26","author":"La Rosa S","year":"2015","unstructured":"La Rosa S, Casnedi S, Maragliano R, et al.. Breast metastasis as the first clinical manifestation of ileal neuroendocrine tumor. A challenging diagnosis with relevant clinical implications. Endocr Pathol. 2015, 26:145-51. 10.1007\/s12022-015-9371-x","journal-title":"Endocr Pathol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.55317","article-title":"Breast metastasis of small bowel carcinoid tumor misdiagnosed as primary breast cancer","volume":"29","author":"Shahrokni A","year":"2009","unstructured":"Shahrokni A, Rajebi MR, Saif MW. Breast metastasis of small bowel carcinoid tumor misdiagnosed as primary breast cancer. Ann Saudi Med. 2009, 29:320-1. 10.4103\/0256-4947.55317","journal-title":"Ann Saudi Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(65)80059-9","article-title":"Solitary breast metastasis from carcinoid of the ileum","volume":"109","author":"Chodoff RJ","year":"1965","unstructured":"Chodoff RJ. Solitary breast metastasis from carcinoid of the ileum. Am J Surg. 1965, 109:814-5. 10.1016\/s0002-9610(65)80059-9","journal-title":"Am J Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.144.2.7089284","article-title":"Breast metastases from extramammary malignancies","volume":"144","author":"Bohman LG","year":"1982","unstructured":"Bohman LG, Bassett LW, Gold RH, Voet R. Breast metastases from extramammary malignancies. Radiology. 1982, 144:309-12. 10.1148\/radiology.144.2.7089284","journal-title":"Radiology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(98)00052-6","article-title":"Bronchial carcinoid tumor metastatic to the breast","volume":"65","author":"Wozniak TC","year":"1998","unstructured":"Wozniak TC, Naunheim KS. Bronchial carcinoid tumor metastatic to the breast. Ann Thorac Surg. 1998, 65:1148-9. 10.1016\/s0003-4975(98)00052-6","journal-title":"Ann Thorac Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3747\/co.v17i6.669","article-title":"Metastatic carcinoid presenting as a breast lesion","volume":"17","author":"Geyer HL","year":"2010","unstructured":"Geyer HL, Viney J, Karlin N. Metastatic carcinoid presenting as a breast lesion. Curr Oncol. 2010, 17:73-7. 10.3747\/co.v17i6.669","journal-title":"Curr Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.02.034","article-title":"Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases","volume":"106","author":"Strosberg J","year":"2007","unstructured":"Strosberg J, Nasir A, Cragun J, Gardner N, Kvols L. Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases. Gynecol Oncol. 2007, 106:65-8. 10.1016\/j.ygyno.2007.02.034","journal-title":"Gynecol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/2156-7514.191439","article-title":"Occult primary neuroendocrine tumor metastasis to the breast detected on screening mammogram","volume":"6","author":"Policeni F","year":"2016","unstructured":"Policeni F, Pakalniskis B, Yang L. Occult primary neuroendocrine tumor metastasis to the breast detected on screening mammogram. J Clin Imaging Sci. 2016, 6:41. 10.4103\/2156-7514.191439","journal-title":"J Clin Imaging Sci"},{"key":"ref35","article-title":"Metastatic neuroendocrine tumor found on screening mammogram","volume":"110","author":"Amin AL","year":"2011","unstructured":"Amin AL, Kong AL. Metastatic neuroendocrine tumor found on screening mammogram. WMJ. 2011, 110:140-5.","journal-title":"WMJ"},{"key":"ref36","article-title":"Non-epithelial malignancies and metastatic tumours of the breast","volume":"78","author":"O'Donnell ME","year":"2009","unstructured":"O'Donnell ME, McCavert M, Carson J, Mullan FJ, Whiteside MW, Garstin WI. Non-epithelial malignancies and metastatic tumours of the breast. Ulster Med J. 2009, 78:105-12.","journal-title":"Ulster Med J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0340","article-title":"Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database","volume":"20","author":"Ter-Minassian M","year":"2013","unstructured":"Ter-Minassian M, Chan JA, Hooshmand SM, et al.. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer. 2013, 20:187-96. 10.1530\/ERC-12-0340","journal-title":"Endocr Relat Cancer"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3275\/8102","article-title":"Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study","volume":"35","author":"Faggiano A","year":"2012","unstructured":"Faggiano A, Ferolla P, Grimaldi F, et al.. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest. 2012, 35:817-23. 10.3275\/8102","journal-title":"J Endocrinol Invest"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160771","article-title":"Principles of diagnosis and management of neuroendocrine tumours","volume":"189","author":"Raphael MJ","year":"2017","unstructured":"Raphael MJ, Chan DL, Law C, Singh S. Principles of diagnosis and management of neuroendocrine tumours. CMAJ. 2017, 189:E398-404. 10.1503\/cmaj.160771","journal-title":"CMAJ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","author":"Ramage JK","year":"2012","unstructured":"Ramage JK, Ahmed A, Ardill J, et al.. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012, 61:6-32. 10.1136\/gutjnl-2011-300831","journal-title":"Gut"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197712)40:6<3102::aid-cncr2820400652>3.0.co;2-n","article-title":"Breast metastasis: an unusual manifestation of a malignant carcinoid tumor","volume":"40","author":"Harrist TJ","year":"1977","unstructured":"Harrist TJ, Kalisher L. Breast metastasis: an unusual manifestation of a malignant carcinoid tumor. Cancer. 1977, 40:3102-6. 10.1002\/1097-0142(197712)40:6&lt;3102::aid-cncr2820400652&gt;3.0.co;2-n","journal-title":"Cancer"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-002-1567-z","article-title":"Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings","volume":"13","author":"G\u00fcnhan-Bilgen I","year":"2003","unstructured":"G\u00fcnhan-Bilgen I, Zekioglu O, Ust\u00fcn EE, Memis A, Erhan Y. Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings. Eur Radiol. 2003, 13:788-93. 10.1007\/s00330-002-1567-z","journal-title":"Eur Radiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.183.4.1831169","article-title":"Primary oat cell carcinoma of the breast: imaging features","volume":"183","author":"Mariscal A","year":"2004","unstructured":"Mariscal A, Balliu E, D\u00edaz R, Casas JD, Gallart AM. Primary oat cell carcinoma of the breast: imaging features. AJR Am J Roentgenol. 2004, 183:1169-71. 10.2214\/ajr.183.4.1831169","journal-title":"AJR Am J Roentgenol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2013.14.3.395","article-title":"Primary neuroendocrine tumor of the breast: imaging features","volume":"14","author":"Chang ED","year":"2013","unstructured":"Chang ED, Kim MK, Kim JS, Whang IY. Primary neuroendocrine tumor of the breast: imaging features. Korean J Radiol. 2013, 14:395-9. 10.3348\/kjr.2013.14.3.395","journal-title":"Korean J Radiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel M","year":"2007","unstructured":"Gabriel M, Decristoforo C, Kendler D, et al.. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007, 48:508-18. 10.2967\/jnumed.106.035667","journal-title":"J Nucl Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.09.006","article-title":"Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors","volume":"165","author":"Tierney JF","year":"2019","unstructured":"Tierney JF, Chivukula SV, Wang X, et al.. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019, 165:644-51. 10.1016\/j.surg.2018.09.006","journal-title":"Surgery"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002809","article-title":"Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment","volume":"270","author":"Lewis A","year":"2019","unstructured":"Lewis A, Raoof M, Ituarte PHG, et al.. Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment. Ann Surg. 2019, 270:1131-7. 10.1097\/SLA.0000000000002809","journal-title":"Ann Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2011.08.006","article-title":"The management of neuroendocrine tumours: current and future medical therapy options","volume":"24","author":"Oberg KE","year":"2012","unstructured":"Oberg KE. The management of neuroendocrine tumours: current and future medical therapy options. Clin Oncol (R Coll Radiol). 2012, 24:282-93. 10.1016\/j.clon.2011.08.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke A","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C, et al.. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009, 27:4656-63. 10.1200\/JCO.2009.22.8510","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin ME","year":"2014","unstructured":"Caplin ME, Pavel M, Cwikla JB, et al.. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014, 371:224-33. 10.1056\/NEJMoa1316158","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER- 1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg J","year":"2021","unstructured":"Strosberg J, Caplin ME, Kunz PL, et al.. 177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER- 1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021, 22:1752-63. 10.1016\/S1470-2045(21)00572-6","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/150023-neuroendocrine-tumor-metastases-to-the-breast-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:51Z","timestamp":1707509091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/150023-neuroendocrine-tumor-metastases-to-the-breast-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.40703","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,20]]}}}